how many sars cov 2 mutations

Notably, scores for residues with mutations described as affecting plasma antibody recognition are also slightly higher on average compared with those with mutations described as affecting mAbs only. ISSN 1740-1534 (online) D.L.R. Preprint at bioRxiv https://doi.org/10.1101/2021.01.06.425392 (2021). There have been a number of missense mutations observed of SARS-CoV-2. They also determined that the region that encodes a gene called ORF3a also encodes an additional gene, which they name ORF3c. Singer, J., Gifford, R., Cotten, M. & Robertson, D. L. CoV-GLUE: A Web Application for Tracking SARS-CoV-2 Genomic Variation. The original version of the virus, D614, was most widely seen in China and other parts of Asia. The N-terminal domain of spike glycoprotein mediates SARS-CoV-2 infection by associating with L-SIGN and DC-SIGN. Preprint at bioRxiv https://doi.org/10.1101/2020.12.28.424451 (2020). SARS-CoV-2 variant biology: immune escape, transmission and fitness, Spike mutation D614G alters SARS-CoV-2 fitness, Challenges and developments in universal vaccine design against SARS-CoV-2 variants, Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide, The way of SARS-CoV-2 vaccine development: success and challenges, SARS-CoV-2 evolution during treatment of chronic infection, Defining the risk of SARS-CoV-2 variants on immune protection, The biological and clinical significance of emerging SARS-CoV-2 variants, SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness, Global Initiative on Sharing All Influenza Data (GISAID), https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563, https://doi.org/10.1101/2020.06.25.170688, https://doi.org/10.1016/j.cell.2020.11.020, https://files.ssi.dk/Mink-cluster-5-short-report_AFO2, https://www.ecdc.europa.eu/sites/default/files/documents/RRA-SARS-CoV-2-in-mink-12-nov-2020.pdf, https://doi.org/10.1101/2020.12.14.422555, https://doi.org/10.1101/2021.02.23.21252268, https://doi.org/10.1038/s41586-021-03291-y, https://virological.org/t/sars-cov-2-reinfection-by-the-new-variant-of-concern-voc-p-1-in-amazonas-brazil/596, https://www.preprints.org/manuscript/202101.0132/v1, https://virological.org/t/spike-e484k-mutation-in-the-first-sars-cov-2-reinfection-case-confirmed-in-brazil-2020/584, https://doi.org/10.1016/j.cell.2021.03.028, https://doi.org/10.1016/j.cell.2021.03.029, https://doi.org/10.1101/2020.11.05.369264, https://doi.org/10.1101/2020.12.28.424451, https://doi.org/10.1101/2021.03.17.435863, https://doi.org/10.1101/2020.10.25.20219063, https://nextstrain.org/ncov/global?c=gt-S_477&gmax=24271&gmin=22482, https://doi.org/10.1101/2021.01.06.425392, https://doi.org/10.1101/2021.03.03.21252812, https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-risk-related-to-spread-of-new-SARS-CoV-2-variants-EU-EEA.pdf, https://doi.org/10.1101/2020.12.30.20249034, https://doi.org/10.1038/s41586-021-03412-7, https://doi.org/10.1101/2021.01.15.426849, https://doi.org/10.1101/2020.12.21.20248640, https://doi.org/10.1016/j.cell.2021.02.042, https://doi.org/10.1038/s41586-021-03471-w, https://virological.org/t/genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-manaus-preliminary-findings/586, https://virological.org/t/phylogenetic-relationship-of-sars-cov-2-sequences-from-amazonas-with-emerging-brazilian-variants-harboring-mutations-e484k-and-n501y-in-the-spike-protein/585, https://cov-lineages.org/global_report.html, https://github.com/cov-lineages/pango-designation/issues/4, https://doi.org/10.1101/2021.02.12.21251658, https://doi.org/10.1101/2021.02.22.432189, https://virological.org/t/resurgence-of-sars-cov-2-19b-clade-corresponds-with-possible-convergent-evolution/620, https://doi.org/10.1101/2021.02.23.21252259, https://doi.org/10.1101/2021.02.14.431043, https://www.krisp.org.za/publications.php?pubid=330, https://doi.org/10.1101/2021.02.08.21251393, https://doi.org/10.1101/2021.04.22.440932, https://doi.org/10.1101/2021.01.07.425740, https://doi.org/10.1038/s41591-021-01270-4, https://doi.org/10.1101/2021.03.01.433314, https://doi.org/10.1016/S0140-6736(21)00628-0, https://doi.org/10.1101/2021.01.26.426986, https://doi.org/10.1101/2021.01.25.427948, https://doi.org/10.1101/2021.02.01.429069, https://doi.org/10.1016/j.cell.2021.03.013, Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection, Development of a screening platform to discover natural products active against SARS-CoV-2 infection using lung organoid models, COVID-19 infection rates and mitigation strategies in orthodontic practices, Revolutionizing viral disease vaccination: the promising clinical advancements of non-replicating mRNA vaccines, Humoral immunity for durable control of SARS-CoV-2 and its variants, Cancel R.R. https://doi.org/10.1093/infdis/jiab082 (2021). Hundreds packed Killian and Hockfield courts to enjoy student performances, amusement park rides, and food ahead of Inauguration Day. Soh, W. T. et al. A relative lack of glycan shielding may contribute to the immunodominance of the RBD33. Due to this aggregation, calculated scores are relatively insensitive to the effects of single amino acid substitutions. A. et al. Nextstrain. ECDC. While the idea of "viral mutation" may sound concerning, it's important to understand that many of these mutations are minor, and don't have an overall impact on how fast a virus spreads or potentially how severe a viral infection might be. In this Review, we explore the literature on these mutations and their antigenic consequences, focusing on the spike protein and antibody-mediated immunity, and discuss them in the context of observed mutation frequencies in global sequence datasets. 6970 is predicted to alter the conformation of an exposed NTD loop and has been reported to be associated with increased infectivity22. Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity. 5b). PubMed 383, 22912293 (2020). Google Scholar. CD, connecting domain; CT cytoplasmic tail; FP, fusion peptide; RBM, receptor-binding motif; TM, transmembrane domain. We have all the tools needed to stop the spread of these new variants, Grubaugh emphasized. Med. The SARS-CoV-2 spike protein is highly glycosylated, with 66 potential N-glycosylation sites per trimer98,99 (Fig. PubMed Central This 140 spike mutant subsequently acquired the E484K mutation, resulting in a further fourfold drop in neutralization titre, and thus a two-residue change across the NTD and the RBD can drastically evade the polyclonal antibody response. Weissman, D. et al. Escape mutations emerging in viruses exposed to convalescent plasma have been identified in both the NTD (F140, N148S, K150R, K150E, K150T, K150Q and S151P) and the RBD (K444R, K444N, K444Q, V445E and E484K)40,41 (Fig. Lancet https://doi.org/10.1016/S0140-6736(21)00628-0 (2021). 6. Serological analyses of almost 650 individuals infected with SARS-CoV-2 indicated that ~90% of the plasma or serum neutralizing antibody activity targets the spike receptor-binding domain (RBD)12. Science 371, 11391142 (2021). Hodcroft, E. B. et al. Image from the Saphire Lab, La Jolla Institute for Immunology. A., Orton, R. J., Singer, J. Andreano, E. et al. Silver, Z. Notability criteria. Figure2c shows that, in general, residues become more accessible and are likelier to form epitopes when the spike protein is in the open conformation, and this is especially true for the RBD, particularly for the upright RBD (Fig. SARS-CoV-2 evolution during treatment of chronic infection. Scientists from The Federal Research Centre "Fundamentals of Biotechnology" of the Russian Academy of Sciences together with foreign colleagues demonstrated that human 14-3-3 proteins, that are known for their role in replication of many viruses, bind differentially with more often mutating regulatory part of nucleoprotein (N protein) of coronavirus SARS-CoV-2. Such mutations may alter various aspects of virus biology, such as pathogenicity, infectivity, transmissibility and/or antigenicity. Letko, M., Marzi, A. Neutralization of UK-variant VUI-202012/01 with COVAXIN vaccinated human serum. The collective data on the effect of mutations on vaccines and convalescent serum efficacy show that the polyclonal antibody response is focused on a few immunodominant regions, indicating the high probability of future mutation-mediated escape from host immunity. Nat Rev Microbiol 19, 409424 (2021). In one example, the researchers identified a region of the nucleocapsid protein, which surrounds the viral genetic material, that had many more mutations than expected from its historical evolution patterns. However, substitutions at 477 were not identified as being important in DMS with convalescent plasma39. Virus Evol. The emergence of SARS-CoV-2 in Europe and North America. Rambaut, A. et al. Epitope scores are particularly high for residues with mutations described as emerging during exposure to convalescent plasma40,41 (Supplementary Fig. This data could help other scientists focus their attention on the mutations that appear most likely to have significant effects on the virus infectivity, the researchers say. Several deletions in the spike amino-terminal domain (NTD) that affect recognition by neutralizing antibodies have been described41,42. Baum, A. et al. & Baldi, P. PEPITO: improved discontinuous B-cell epitope prediction using multiple distance thresholds and half sphere exposure. Over time, the cumulative effects of these mutations may be enough to change how the virus behaves. This approach calculates a structure-based epitope score, which approximates antibody accessibility for each amino acid position. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. The spike amino acid substitution with the second highest frequency is A222V, which is present in the 20A.EU1 SARS-CoV-2 cluster (also designated lineage B.1.177). Sci. This was despite the plasma being a source of the highly potent RBD-targeting mAb C144 (ref.40). As antigenically different variants are continuing to emerge, it will become necessary to routinely collect serum samples from vaccinated individuals and from individuals who have been infected with circulating variants of known sequence. Hu, J. et al. One study described multiple mAbs that selected for the emergence of S477N and found this mutant to be resistant to neutralization by the entire panel of RBD-targeting mAbs that were tested. . Med. This website is managed by the MIT News Office, part of the Institute Office of Communications. A lineage is a genetically closely related group of virus variants derived from a common ancestor. Kidd, M. et al. On average, variant frequency is higher at amino acid positions where mutations are described as affecting antibody recognition than at positions with no described substitutions of antigenic importance (Supplementary Fig. The spike protein mediates attachment of the virus to host cell-surface receptors and fusion between virus and cell membranes11 (Box1). Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. A change in the biophysical properties of an epitope residue directly diminishes antibody binding. In the NTD, most of the evidence for immune evasion focuses on a region centred at a conformational epitope consisting of residues 140156 (N3 loop) and 246260 (N5 loop), which includes the epitope of the antibody 4A832 (Fig. Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodies. This umbrella includes, for instance, the lineages XBB.1.5, XBB.1.9.1*, XBB.1.9.2*, and XBB.1.16 All sub-lineages of the listed lineages are also included in the variant b | Aligned heat maps showing properties of amino acid residues where substitutions affect binding by antibodies in polyclonal human blood plasma or emerge as antibody escape mutations. 3). Therefore, mutations in that region may help the virus evade the human immune system, Kellis says. Another RBM amino acid change, Y453F associated with increased ACE2-binding affinity19 received considerable attention following its identification in sequences associated with infections in humans and mink; most notably one lineage identified in Denmark and initially named cluster 5 (now B.1.1.298)20. Nature Reviews Microbiology thanks Y. Wang and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. The residues comprising the receptor-binding motif are revealed on the upright RBD, enabling binding to ACE2, which induces a progressively more open structure until a fully open, three-ACE2-bound structure is formed, initiating S2 unsheathing and membrane fusion101. Duchene, S. et al. But luckily with vaccines, you dont just create one antibodyor two or threeyou create many different antibodies that recognize different parts of the virus.. & Robertson, D. L. No evidence for distinct types in the evolution of SARS-CoV-2. Preprint at bioRxiv https://doi.org/10.1101/2021.02.22.432189 (2021). SARS-CoV-2 can enter cells by two main pathways. For strains that have many mutations, we can see which of these mutations are likely to be host-specific adaptations, and which mutations are perhaps nothing to write home about.. Nat. J. Virol. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects. Domains are coloured as in part a. Monophyletic clusters of viruses assigned on the basis of the severe acute reparatory syndrome coronavirus 2 (SARS-CoV-2) global phylogenetic tree. Wise, J. Covid-19: the E484K mutation and the risks it poses. The RCSB Protein Data Bank IDs for the SARS-CoV-2 spike protein structures are 6ZGG and 6ZGE50. A new variant carrying E484K currently designated A.VOI.V2 was recently identified in Angola from cases involving travel from Tanzania79. Most mutations . Preprint at bioRxiv https://doi.org/10.1101/2020.11.05.369264 (2020). Faulkner, N. et al. Hensley, S. E. et al. A substitution can introduce an additional N-linked glycosylation motif. Other experiments with pseudotyped viruses showed that the B.1.351 variant was also resistant to the neutralizing activity of some mAbs (12 of 17; 70%)67. A list of members and their affiliations appears in Supplementary information. Preprint at bioRxiv https://doi.org/10.1101/2020.06.25.170688 (2020). In common with other virus surface glycoproteins responsible for attachment to host cell-surface receptors, such as influenza virus haemagglutinin and the envelope glycoprotein GP120 of HIV, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein is an important target for neutralizing antibodies. Google Scholar. D614G refers to an amino acid mutation in this protein that has become increasingly common in SARS-CoV-2 viruses from around the world. Although significant interperson and intraperson heterogeneity in the impact of mutations on neutralization by polyclonal serum has been described, the mutations that reduce antibody binding the most occur at a relatively small number of RBD residues, indicating substantial immunodominance within the RBD39. Watanabe, Y., Allen, J. D., Wrapp, D., McLellan, J. S. & Crispin, M. Site-specific glycan analysis of the SARS-CoV-2 spike. researched data for the article. Tracking the emergence of these viruses flagged as potential antigenically significant variants will help to guide the implementation of targeted control measures and further laboratory characterization. Notably, mutations emerging under selective pressure from convalescent plasma may be different from those selected by the most frequent mAb isolated from the same plasma40. J. This gene-within-a-gene is rare in large genomes, but common in many viruses, whose genomes are under selective pressure to stay compact. Biol. Choi, B. et al. Pseudoviruses carrying the set of B.1.1.7 spike mutations evaluated with postvaccination serum from individuals who received the BNT162b2 vaccine (two doses)63,78,84 or mRNA-1273 vaccine (two doses)63 exhibited only a modest reduction in neutralization titres (less than threefold). CAS The presence of a polybasic furin cleavage site at the S1S2 boundary, which is unique within the subgenus Sarbecovirus, is important for infectivity and virulence100, with furin cleavage facilitating the conformational change required for receptor binding50. Based on current data, it seems as though SARS-CoV-2 mutates much more slowly than the seasonal flu. The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity. D614G spike mutation increases SARS CoV-2 susceptibility to neutralization. and D.L.R. Cell https://doi.org/10.1016/j.cell.2020.11.020 (2020). a | Structure-based antibody accessibility scores for each spike protein ectodomain residue in the closed form were calculated with BEpro49. High numbers of B.1.351 viruses also have the spike amino acid substitutions L18F, R246I and D614G. While many of its genes were already known at that point, the full complement of protein-coding genes was unresolved. Preprint at bioRxiv https://doi.org/10.1101/2021.01.25.427948 (2021). Residue 501 is at the RBDACE2 interface (Fig. The S1S2 boundary is at amino acid position 685. b | Spike protein monomer displaying an upright receptor-binding domain (RBD). Given that therapeutics (vaccines and antibody-based therapies) target mainly the SARS-CoV-2 spike protein, the selection pressures that favour the emergence of new variants carrying immune escape mutations generated in chronic infections24,25,26 will be similar to those selecting for mutations that allow reinfections within the wider population27,28,29. The event was spotted in infrared data also a first suggesting further searches in this band could turn up more such bursts. The B.1.1.7 spike mutations have been shown to diminish neutralization of a higher proportion of NTD-specific neutralizing antibodies (9 of 10; 90%) than RBD-specific neutralizing antibodies (5 of 31; 16%)63. volume19,pages 409424 (2021)Cite this article. https://doi.org/10.1038/s41591-021-01270-4 (2021). A comprehensive understanding of the consequences of spike mutations for antigenicity will encompass both T cell-mediated immunity and non-spike epitopes recognized by antibodies. They are defined by multiple convergent mutations that are hypothesized to have arisen either in the context of chronic infections or in previously infected individuals24,25,26,27,28,29. https://www.gisaid.org, Global Report Investigating Novel Coronavirus Haplotypes: Within the RBD, the two areas with high structure-based antibody accessibility scores for the closed spike structure (Fig. Coronavirus (COVID-19) Dashboard. The risk is likely to be reduced with the use of cocktails of two or more mAbs targeting non-overlapping epitopes. Global Report Investigating Novel Coronavirus Haplotypes. Compared with wild type, pseudoviruses with D614G or the mutations defining lineages B.1.1.7, B.1.1.298 and B.1.429 each showed non-statistically significant decreases in neutralization90. David L. Robertson. Data reported in one study showed that nearly half of examined convalescent plasma samples (21 of 44; 48%) had no detectable neutralization activity against the B.1.351 variant58. The most accelerated region in the entire genome of SARS-CoV-2 is sitting smack in the middle of this nucleocapsid protein, he says. Watanabe, Y. et al. Kellis has previously developed computational techniques for doing this type of analysis, which his team has also used to compare the human genome with genomes of other mammals. Lineages P.1 and P.2 each showed significant decreases, with both BNT162b2 (6.7-fold and 5.8-fold, respectively) and mRNA-1273 (4.5-fold and 2.9-fold, respectively) postvaccination sera90. Struct. Science https://doi.org/10.1126/science.abd0831 (2020). The COVID-19 Genomics UK (COG-UK) Consortium is supported by funding from the UK Medical Research Council (MRC), part of UK Research and Innovation, the UK National Institute of Health Research and Genome Research Limited, operating as the Wellcome Sanger Institute. For each gene, they compared how rapidly that particular gene has evolved in the past with how much it has evolved since the current pandemic began. We analyzed the entire genome and are very confident that there are no other conserved protein-coding genes, says Irwin Jungreis, lead author of the study and a CSAIL research scientist. Immunol. In addition to N3, high-scoring residues (greater than 0.7) are found at positions 2226 (N1), 70 (N2), 173187 (N4), 207213 (Fig. 4a).The SARS-CoV-2 spike protein is post-translationally cleaved by mammalian furin into two subunits: S1 and S2 (Fig. At that time, it was called the L strain. WHO. Avanzato, V. A. et al. Fewer data on the antigenic effects of S2 mutations exist, though D769H has been described as conferring decreased susceptibility to neutralizing antibodies24. Cell Host Microbe 29, 463476 e466 (2021). Greaney, A. J. et al. Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization. Among the 5,106 independent substitutions observed in the spike protein (Box1), 161 are described as affecting recognition by mAbs or polyclonal antibodies in sera, of which 22 are present in more than 100 sequences. Although most mutations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome are expected to be either deleterious and swiftly purged or relatively neutral, a small proportion will affect functional properties and may alter infectivity, disease severity or interactions with host immunity. Detection of new SARS-CoV-2 Variants Related to Mink. . d | Two surface colour representations of antibody accessibility scores for the spike protein in the open conformation with a single monomer with an upright RBD are shown: a trimer axis vertical view (left) and an orthogonal top-down view along this axis (right). Evol. Of the three RBD amino acid substitutions present in several thousand sequences, N439K and N501Y were described earlier, and N501Y is discussed in more detail in the next section in the context of variants of concern. (mAbs). 5, several amino acid substitutions are convergent, having arisen independently in different lineages: N501Y, which is present in lineages B.1.1.7, B.1.351 and P.1; E484K, which is present in lineages B.1.351 and P.1 and has been detected as emerging within the B.1.1.7 lineage55; and H69V70 in lineages B.1.1.298 and B.1.1.7. Here's what scientists are watching for: Like all viruses, SARS-CoV-2 is mutating as it passes from person to person. 2b). https://www.cogconsortium.uk, CoV-GLUE A Web Application for Tracking SARS-CoV-2 Genomic Variation: Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Nat. A limitation of this approach is that it does not account for glycan shielding of residues and likely overestimates scores at the base of the ectodomain for residues closest to the carboxy terminus. Thats because mutations always arise as viruses spread. The phenomenon by which the host immune response against a viral particle is mostly focused on a few antigens and mediated by potently neutralizing antibodies. Article Whereas K417 is described in the epitopes of RBD class 1 and class 2 antibodies31, alterations to K417 tend to affect class 1 antibody binding and are therefore somewhat less important for the polyclonal antibody response to the RBD, which is dominated by class 2 antibody responses, which are more susceptible to substitutions such as E484K44,58,59. Immunol. Molnupiravir, an antiviral medication that has been widely used against SARS-CoV-2, acts by inducing mutations in the virus genome during replication. The specific parts of an antigen recognized by the immune system: antibodies, B cells or T cells. SARS-CoV-2 is an enveloped RNA virus, which means that its genetic material is encoded in single-stranded RNA. The ChAdOx1 nCoV-19 vaccine showed clinical efficacy against the B.1.1.7 variant but failed to provide protection against mild to moderate disease caused by the B.1.351 variant, with vaccine efficacy against the variant estimated at 10.4% (95% confidence interval 76.8 to 54.8)85,86,91. Experiments have shown that H69V70 does not reduce neutralization by a panel of convalescent sera; however, it may compensate for infectivity deficits associated with affinity-boosting RBM mutations that may emerge due to immune-mediated selection22. Thank you for visiting nature.com. Genomic epidemiology of novel coronavirus - Global subsampling. 725422 ReservoirDOCS). de Oliveira, T. et al. In addition to single mutations of note, more heavily mutated SARS-CoV-2 lineages have emerged. Naveca, F. et al. Weisblum, Y. et al. Genomic Evidence of a SARS-Cov-2 Reinfection Case with E484K Spike Mutation in Brazil. Use the Previous and Next buttons to navigate the slides or the slide controller buttons at the end to navigate through each slide. 4b). Preprint at medRxiv https://doi.org/10.1101/2020.12.21.20248640 (2020). ISSN 1740-1526 (print). In an escape mutation study using 19 mAbs, substitutions at E484 emerged more frequently than at any other residue (in response to four mAbs), and each of the four 484 mutants identified (E484A, E484D, E484G and E484K) subsequently conferred resistance to each of four convalescent sera tested48. The co-occurrence of Y144 and E484K is concerning with respect to the polyclonal antibody response as the N3 loop, which Y144 changes, is predicted to be among the most immunogenic regions of the spike protein (Fig. SARS-CoV-2 variants of concern tend to emerge mutations in the S1 unit of the spike protein, which includes the RBDs and is responsible for binding to the ACE2 receptor. The rate of evolution of SARS-CoV-2 from December 2019 to October 2020 was consistent with the virus acquiring approximately two mutations per month in the global population15,16. 2c). 18, 10611063 (2021). Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma. However, each of those variants carries other mutations as well. McCallum, M. et al. Garcia-Beltran, W. F. et al. Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020. Epitope binning of 41 NTD-specific mAbs led to the identification of six antigenic sites, one of which is recognized by all known NTD-specific neutralizing antibodies and has been termed the NTD supersite, consisting of residues 1420, 140158 and 245264 (ref.30) (Fig. You may not alter the images provided, other than to crop them to size. As of April 2021, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, accounted for more than 143 million infections and more than three million deaths worldwide1.
Colorado Speed Limit Map, How To Replace A Lost Learners Permit Nj, Georgia Inmate Killed 2021, Jacuzzi Vs Hayward Pool Pump, Articles H